awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36599503-54345D4D-8FD1-43C2-A22C-631B984025D4
Q36599503-54345D4D-8FD1-43C2-A22C-631B984025D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36599503-54345D4D-8FD1-43C2-A22C-631B984025D4
Dynamic fractal signature dissimilarity analysis for therapeutic response assessment using dynamic contrast-enhanced MRI.
P2860
Q36599503-54345D4D-8FD1-43C2-A22C-631B984025D4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36599503-54345D4D-8FD1-43C2-A22C-631B984025D4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
022f83c55881d9e17c277b4ad74999eae3032c5c
P2860
FDA drug approval summary: bevacizumab (Avastin) plus Carboplatin and Paclitaxel as first-line treatment of advanced/metastatic recurrent nonsquamous non-small cell lung cancer.